Mayne Pharma Group Limited (ASX:MYX)
6.79
-0.11 (-1.59%)
May 13, 2025, 4:10 PM AEST
Revenue by Product
Fiscal year is July - June.
Year Ending | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 |
---|---|---|---|---|---|
Dermatology | 174.86M |
Log In |
Log In |
Log In |
Log In |
Dermatology Growth | 206.81% |
Log In |
Log In |
Log In |
Log In |
Womens Health | 142.83M |
Log In |
Log In |
Log In |
Log In |
Womens Health Growth | 130.78% |
Log In |
Log In |
Log In |
Log In |
International | 70.71M |
Log In |
Log In |
Log In |
Log In |
International Growth | 9.29% |
Log In |
Log In |
Log In |
Log In |
Metrics Contract Services | - |
Log In |
Log In |
Log In |
Log In |
Metrics Contract Services Growth | - |
Log In |
Log In |
Log In |
Log In |
Generic Products | - |
Log In |
Log In |
Log In |
Log In |
Generic Products Growth | - |
Log In |
Log In |
Log In |
Log In |
Specialty Products | - |
Log In |
Log In |
Log In |
Log In |
Specialty Products Growth | - |
Log In |
Log In |
Log In |
Log In |
Revenue by Geography
Fiscal year is July - June.
Year Ending | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 |
---|---|---|---|---|---|
United States | 322.13M |
Log In |
Log In |
Log In |
Log In |
United States Growth | 158.81% |
Log In |
Log In |
Log In |
Log In |
Australia and New Zealand | 40.34M |
Log In |
Log In |
Log In |
Log In |
Australia and New Zealand Growth | -2.09% |
Log In |
Log In |
Log In |
Log In |
Canada | 13.37M |
Log In |
Log In |
Log In |
Log In |
Canada Growth | 34.62% |
Log In |
Log In |
Log In |
Log In |
Europe and Other | 7.13M |
Log In |
Log In |
Log In |
Log In |
Europe and Other Growth | 98.00% |
Log In |
Log In |
Log In |
Log In |
Asia | 5.44M |
Log In |
Log In |
Log In |
Log In |
Asia Growth | 23.78% |
Log In |
Log In |
Log In |
Log In |
Australia | - |
Log In |
Log In |
Log In |
Log In |
Australia Growth | - |
Log In |
Log In |
Log In |
Log In |
Other | - |
Log In |
Log In |
Log In |
Log In |
Other Growth | - |
Log In |
Log In |
Log In |
Log In |